top border
top border
Featured Programs
Ibrutinib in Relapsed Mantle Cell Lymphoma
Drs Danilov, Goy, Leonard, Pagel, and Schuster, discuss ibrutinib (Imbruvica) as a treatment in relapsed mantle cell lymphoma. View Now

Brad S. Kahl, MD, and Richard R. Furman, MD, explain available treatment options for relapsed mantle cell lymphoma. View Now

 

Featured Video
Dr. Esteva on the Future of Biosimilars in Breast Cancer
Francisco J. Esteva, MD, PhD, director, breast medical oncology program, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, discusses the future use of biosimilars in breast cancer within the United States. View now
Kristi Rosa

Gina Columbus highlights the latest news from the 2019 ASH Annual Meeting in this week's OncLive News Network.

Publication Bottom Border
Border Publication
x